Novacyt (NCYT) EUR0.0667 (CDI)

Sell:30.50pBuy:32.90pPrice increased1.30p (4.10%)

Prices delayed by at least 15 minutes
Sell:30.50p
Buy:32.90p
Change:Price increased1.30p (4.10%)
Prices delayed by at least 15 minutes
Sell:30.50p
Buy:32.90p
Change:Price increased1.30p (4.10%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
27 March 2026
Ian David GilhamNon-Executive Director
Buy
Regular purchase transaction
28,750£0.34£9,895.7557,500
26 March 2026
John Robert BrownChairman of the Board
Buy
Regular purchase transaction
1,802€0.40€711.79217,512
26 March 2026
John Robert BrownChairman of the Board
Buy
Regular purchase transaction
56,732€0.39€22,233.27215,710
26 March 2026
John Robert BrownChairman of the Board
Buy
Regular purchase transaction
15,228€0.38€5,812.53158,978
26 March 2026
Lyn ReesCEO
Buy
Regular purchase transaction
1,792€0.39€706.94145,254
26 March 2026
Lyn ReesCEO
Buy
Regular purchase transaction
56,438€0.39€22,118.05143,462
26 March 2026
Lyn ReesCEO
Buy
Regular purchase transaction
15,149€0.38€5,782.3787,024

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
26 March 2026
John Robert BrownChairman of the Board
Buy
Regular purchase transaction
56,732€0.39€22,233.27215,710
26 March 2026
Lyn ReesCEO
Buy
Regular purchase transaction
56,438€0.39€22,118.05143,462
27 March 2026
Ian David GilhamNon-Executive Director
Buy
Regular purchase transaction
28,750£0.34£9,895.7557,500
26 March 2026
John Robert BrownChairman of the Board
Buy
Regular purchase transaction
15,228€0.38€5,812.53158,978
26 March 2026
Lyn ReesCEO
Buy
Regular purchase transaction
15,149€0.38€5,782.3787,024

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.